3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
TP53 Y220C Mutation
1
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Deglutition Disorders
1
Cognitive Dysfunction
1
Interventions
Dexamethasone
120
Lenalidomide
72
daratumumab
69
Bortezomib
56
pomalidomide
45
carfilzomib
42
Cyclophosphamide
39
Calcium Dobesilate
33
Specimen Handling
31
Biopsy
29
Magnetic Resonance Spectroscopy
26
belantamab mafodotin
21
fludarabine
20
talquetamab
19
isatuximab
17
iberdomide
17
dexamethasone acetate
14
dexamethasone 21-phosphate
14
auricularum
14
Melphalan
14
fludarabine phosphate
12
elotuzumab
12
tocilizumab
9
selinexor
8
X-Rays
8
Nivolumab
8
trametinib
7
Whole-Body Irradiation
6
Sirolimus
6
Crizotinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Tablets
×
90 days
×
Clear all
No trials found.